Cart
sales@molnova.com
6-Phenyldihydropyrimidine-2,4(1h,3h)-dione
CAS No. 6300-95-4
6-Phenyldihydropyrimidine-2,4(1h,3h)-dione( 2,4(1H,3H)-Pyrimidinedione,dihydro-6-phenyl- )
Catalog No. M22230 CAS No. 6300-95-4
6-Phenyldihydropyrimidine-2,4(1h,3h)-dione targets the polypyrimidine tract-binding protein 1 isoform a (human).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 177 | Get Quote |
|
| 5MG | 268 | Get Quote |
|
| 10MG | 408 | Get Quote |
|
| 25MG | 672 | Get Quote |
|
| 50MG | 945 | Get Quote |
|
| 100MG | 1278 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name6-Phenyldihydropyrimidine-2,4(1h,3h)-dione
-
NoteResearch use only, not for human use.
-
Brief Description6-Phenyldihydropyrimidine-2,4(1h,3h)-dione targets the polypyrimidine tract-binding protein 1 isoform a (human).
-
Description6-Phenyldihydropyrimidine-2,4(1h,3h)-dione targets the polypyrimidine tract-binding protein 1 isoform a (human).
-
In Vitro——
-
In Vivo——
-
Synonyms2,4(1H,3H)-Pyrimidinedione,dihydro-6-phenyl-
-
PathwayOthers
-
TargetOther Targets
-
Recptorpolypyrimidine tract-binding protein 1 isoform a (human)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6300-95-4
-
Formula Weight190.2
-
Molecular FormulaC10H10N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C[C@@]([H])(NC(=O)N1)c2ccccc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2614W94
2614W94 is a selective, competitive, and reversible inhibitor of monoamine oxidase-A with IC50 of 5 nM and Ki of 1.6 nM with serotonin as a substrate.
-
5'-Deoxy-5-fluoro-N-...
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate is an intermediate in the synthesis of capecitabine.
-
MFZ 10-7
MFZ 10-7 is anegative allosteric modulator of the mGluR5. In rats, MFZ 10-7 (i.p.) inhibits cocaine-induced reinstatement of drug-seeking behavior, cocaine-associated cue-induced cocaine-seeking behavior and intravenous cocaine self-administration.
